Related Experiment Video
Updated: May 28, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Development of Kamala-Based, a Thai Traditional Remedy, Nanoemulsion Gel and In Vitro Release Behavior of
Siraporn Mahakoat1, Sujaree Panomket2, Catheleeya Mekjaruskul3
1Master of Science Program in Herbals and Thai Traditional Medicine, Faculty of Pharmacy, Mahasarakham University, Maha Sarakham 44150, Thailand.
Abstract:
Kamala is a traditional Thai herbal knee poultice containing phenylbutenoid compounds with potent anti-inflammatory activity; however, its conventional form is inconvenient to use and exhibits variability in active compound content. This study aimed to develop a Kamala-based nanoemulsion gel to enhance dermal delivery and improve formulation consistency. Oils, surfactants, and co-surfactants were screened for their solubilization efficiency of (E)-1-(3,4-dimethoxyphenyl)butadiene (DMPBD) and (E)-4-(3',4'-dimethoxyphenyl)but-3-en-1-ol (Compound D) using GC-MS. Pseudo-ternary phase diagrams were constructed to identify isotropic regions, and nanoemulsions with different Smix ratios were prepared by ultrasonication. Droplet size, polydispersity index (PDI), and short-term stability were evaluated. The optimized nanoemulsion was incorporated into a gel, and in vitro release was assessed using Franz diffusion cells. Coconut oil exhibited the highest solubilization capacity for both markers. A Tween 80:n-butanol system (2:1) generated the largest isotropic region (22.88%). The optimized formulation (Kamala extract:coconut oil:Smix:water = 1:2:50:47) showed droplet sizes of 77.92 ± 8.34 nm at 0 h and 130.89 ± 29.16 nm at 72 h, with PDI < 0.20. The nanoemulsion gel prepared with Aristoflex Velvet® (1% w/w) was transparent and physically stable. Franz diffusion studies demonstrated enhanced cumulative release and flux of Compound D in PBS containing 1% Tween 80. These findings indicate that the Kamala nanoemulsion gel is a promising topical delivery system for phenylbutenoid compounds in knee osteoarthritis.